VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+30.34%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$14.8B
AUM Growth
+$2.24B
(+18%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
30.47%
Holding
845
New
82
Increased
442
Reduced
285
Closed
30
Top Buys
| 1 |
B
Barrick Mining Corporation
B
|
$187M |
| 2 |
Harmony Gold Mining
HMY
|
$85.6M |
| 3 |
Franco-Nevada
FNV
|
$80.6M |
| 4 |
First Majestic Silver
AG
|
$64.4M |
| 5 |
Newmont
NEM
|
$60.6M |
Top Sells
| 1 |
Schlumberger
SLB
|
$88.2M |
| 2 |
AngloGold Ashanti
AU
|
$80.3M |
| 3 |
SE
Spectra Energy Corp Wi
SE
|
$44.8M |
| 4 |
Royal Gold
RGLD
|
$44.4M |
| 5 |
Qualcomm
QCOM
|
$43M |
Sector Composition
| 1 | Materials | 48.83% |
| 2 | Energy | 21.69% |
| 3 | Healthcare | 7.09% |
| 4 | Industrials | 2.61% |
| 5 | Communication Services | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sanofi
SNY
$111B
| $12.9M | 0.09% |
322,003
-108,543
| -25% | -$4.36M |
|
152
Pfizer
PFE
$139B
| $12.9M | 0.09% |
459,217
-182,324
| -28% | -$5.13M |
|
153
United Therapeutics
UTHR
$17.2B
| $12.9M | 0.09% |
115,355
-15,141
| -12% | -$1.69M |
|
154
Bristol-Myers Squibb
BMY
$95.1B
| $12.6M | 0.09% |
197,702
-66,519
| -25% | -$4.25M |
|
155
Novo Nordisk
NVO
$250B
| $12.6M | 0.09% |
465,758
-173,078
| -27% | -$4.69M |
|
|
SHPG
156
DELISTED
Shire pic
SHPG
| $12.6M | 0.08% |
73,307
-9,343
| -11% | -$1.61M |
|
|
MHG
157
DELISTED
Marine Harvest ASA
MHG
| $12.6M | 0.08% |
821,630
-80,383
| -9% | -$1.23M |
|
158
Abbott
ABT
$231B
| $12.4M | 0.08% |
296,886
-65,894
| -18% | -$2.76M |
|
159
Cencora
COR
$56.6B
| $12.2M | 0.08% |
140,438
+3,278
| +2% | +$284K |
|
160
Eli Lilly
LLY
$668B
| $11.9M | 0.08% |
165,526
-34,816
| -17% | -$2.51M |
|
161
Toro Company
TTC
$7.77B
| $11.5M | 0.08% |
266,192
-19,802
| -7% | -$853K |
|
|
TSNU
162
DELISTED
Tyson Foods, Inc.
TSNU
| $11.3M | 0.08% |
151,703
+8,453
| +6% | +$630K |
|
163
AstraZeneca
AZN
$253B
| $11.2M | 0.08% |
398,281
-89,241
| -18% | -$2.51M |
|
164
FMC
FMC
$4.61B
| $11.2M | 0.08% |
319,464
-57,007
| -15% | -$2M |
|
165
Teva Pharmaceuticals
TEVA
$21.3B
| $11M | 0.07% |
204,714
-44,405
| -18% | -$2.38M |
|
166
Walmart
WMT
$803B
| $10.8M | 0.07% |
472,878
-1,848,441
| -80% | -$42.2M |
|
167
Alnylam Pharmaceuticals
ALNY
$59.3B
| $10.8M | 0.07% |
171,879
-21,991
| -11% | -$1.38M |
|
168
Broadcom
AVGO
$1.44T
| $10.2M | 0.07% |
659,180
-76,990
| -10% | -$1.19M |
|
169
Tesla
TSLA
$1.08T
| $10.2M | 0.07% |
663,615
+92,385
| +16% | +$1.42M |
|
|
FTRPR
170
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $10.2M | 0.07% |
97,343
+5,420
| +6% | +$566K |
|
171
Gold Resource Corp
GORO
$89.2M
| $10.1M | 0.07% |
4,352,348
+441,838
| +11% | +$1.03M |
|
172
Texas Instruments
TXN
$171B
| $10.1M | 0.07% |
176,080
-40,562
| -19% | -$2.33M |
|
173
ASML
ASML
$296B
| $9.82M | 0.07% |
97,786
-21,523
| -18% | -$2.16M |
|
174
Sunrun
RUN
$3.86B
| $9.78M | 0.07% |
1,509,046
+105,146
| +7% | +$681K |
|
175
Charles River Laboratories
CRL
$7.94B
| $9.67M | 0.07% |
127,396
+7,389
| +6% | +$561K |
|